Atossa Therapeutics Price Chart
Atossa Therapeutics Volume Chart
Atossa Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $4.97 |
|---|---|
| Close | $4.97 |
| Low | $4.97 |
| Low Change | 0.00 (0.00%) |
| High | $4.97 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.25K |
| Dollar Volume | $6.21K |
Regular Trading Hours
+0.03(+0.61%)
| Open | $4.93 |
|---|---|
| Close | $4.96 |
| Low | $4.84 |
| Low Change | -0.09 (-1.86%) |
| High | $5.10 |
| High Change | +0.17 (+3.45%) |
| Range | $0.26 |
| Volume | 23.082K |
| Dollar Volume | $114.49K |
Premarket
+0.00(+0.00%)
| Open | $5.00 |
|---|---|
| Close | $5.00 |
| Low | $5.00 |
| Low Change | 0.00 (0.00%) |
| High | $5.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 400 |
| Dollar Volume | $2.00K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.19(+3.97%)
| Open | $4.79 |
|---|---|
| Close | $4.98 |
| Low | $4.66 |
| Low Change | -0.13 (-2.71%) |
| High | $5.06 |
| High Change | +0.27 (+5.64%) |
| Range | $0.40 |
| Volume | 47.138K |
| Dollar Volume | $234.75K |
Premarket Yesterday
*No Trades in Segment
Atossa Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $4.86 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.02 |
| 20 Day Moving Average (SMA20) | $5.28 |
| 50 Day Moving Average (SMA50) | $5.31 |
| 100 Day Moving Average (SMA100) | $6.02 |
| 200 Day Moving Average (SMA200) | $9.25 |
Atossa Therapeutics Statistics
| Average Volume (30 Days) | 55.13K |
|---|---|
| P/E Ratio (Current) | -1.14 |
| EPS (Current) | -$4.37 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$33.40M |
| Cash Ratio | 4.25 |
| Current Ratio | 4.90 |
| Quick Ratio | 4.50 |
| Debt to Equity | 0.00 |
| Enterprise Value | $11.08M |
| EV to EBITDA | -0.28 |
| EV to Sales | — |
| Price to Book | 1.40 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.99% |
| Return on Equity | -1.23% |
Atossa Therapeutics Stock Splits
There have been 3 stock splits for Atossa Therapeutics (ATOS). The last reverse stock split occured on February 2, 2026 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Feb 2, 2026 | Reverse | 15:1 |
| Apr 20, 2018 | Reverse | 12:1 |
| Aug 26, 2016 | Reverse | 15:1 |
Atossa Therapeutics Dividends
There have been no dividends for Atossa Therapeutics (ATOS).